Frohman EM, Racke MK, Raine CS: Multiple sclerosis - the plaque and its pathogenesis. N Engl J Med. 2006, 354: 942-955. 10.1056/NEJMra052130.
Article
CAS
PubMed
Google Scholar
LeVine SM: Iron deposits in multiple sclerosis and Alzheimer’s disease brains. Brain Res. 1997, 760: 298-303. 10.1016/S0006-8993(97)00470-8.
Article
CAS
PubMed
Google Scholar
Adams CW: Perivascular iron deposition and other vascular damage in multiple sclerosis. J Neurol Neurosurg Psychiatry. 1988, 51: 260-265. 10.1136/jnnp.51.2.260.
Article
CAS
PubMed
PubMed Central
Google Scholar
Adams CW, Poston RN, Buk SJ: Pathology, histochemistry and immunocytochemistry of lesions in acute multiple sclerosis. J Neurol Sci. 1989, 92: 291-306. 10.1016/0022-510X(89)90144-5.
Article
CAS
PubMed
Google Scholar
Stankiewicz J, Panter SS, Neema M, Arora A, Batt CE, Bakshi R: Iron in chronic brain disorders: imaging and neurotherapeutic implications. Neurotherapeutics. 2007, 4: 371-386. 10.1016/j.nurt.2007.05.006.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sullivan JL: Is stored iron safe?. J Lab Clin Med. 2004, 144: 280-284. 10.1016/j.lab.2004.10.006.
Article
CAS
PubMed
Google Scholar
Emerit J, Beaumont C, Trivi F: Iron metabolism, free radicals, and oxidative injury. Biomed Pharmacother. 2001, 55: 333-339. 10.1016/S0753-3322(01)00068-3.
Article
CAS
PubMed
Google Scholar
Rouault TA, Cooperman S: Brain iron metabolism. Semin Pediatr Neurol. 2006, 13: 142-148. 10.1016/j.spen.2006.08.002.
Article
PubMed
Google Scholar
Stankiewicz JM, Brass SD: Role of iron in neurotoxicity: a cause for concern in the elderly?. Curr Opin Clin Nutr Metab Care. 2009, 12: 22-29. 10.1097/MCO.0b013e32831ba07c.
Article
CAS
PubMed
Google Scholar
Li X, Jankovic J, Le W: Iron chelation and neuroprotection in neurodegenerative diseases. J Neural Transm. 2011, 118: 473-477. 10.1007/s00702-010-0518-0.
Article
CAS
PubMed
Google Scholar
LeVine SM, Chakrabarty A: The role of iron in the pathogenesis of experimental allergic encephalomyelitis and multiple sclerosis. Ann N Y Acad Sci. 2004, 1012: 252-266. 10.1196/annals.1306.021.
Article
CAS
PubMed
Google Scholar
Zamboni P: The big idea: iron-dependent inflammation in venous disease and proposed parallels in multiple sclerosis. J R Soc Med. 2006, 99: 589-593. 10.1258/jrsm.99.11.589.
Article
PubMed
PubMed Central
Google Scholar
Simka M, Rybak Z: Hypothetical molecular mechanisms by which local iron overload facilitates the development of venous leg ulcers and multiple sclerosis lesions. Med Hypotheses. 2008, 71: 293-297. 10.1016/j.mehy.2008.02.009.
Article
CAS
PubMed
Google Scholar
Zamboni P, Izzo M, Tognazzo S, Carandina S, De Palma M, Catozzi L, Caggiati A, Scapoli G, Gemmati D: The overlapping of local iron overload and HFE mutation in venous leg ulcer pathogenesis. Free Radic Biol Med. 2006, 40: 1869-1873. 10.1016/j.freeradbiomed.2006.01.026.
Article
CAS
PubMed
Google Scholar
Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A: A novel MHC class I like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996, 13: 399-408. 10.1038/ng0896-399.
Article
CAS
PubMed
Google Scholar
Gemmati D, Federici F, Catozzi L, Gianesini S, Tacconi G, Scapoli GL, Zamboni P: DNA-array of gene variants in venous leg ulcers: detection of prognostic indicators. J Vasc Surg. 2009, 50: 1444-1451. 10.1016/j.jvs.2009.07.103.
Article
PubMed
Google Scholar
Rubio JP, Bahlo M, Tubridy N, Stankovich J, Burfoot R, Butzkueven H: Extended haplotype analysis in the HLA complex reveals an increased frequency of the HFE-C282Y mutation in individuals with multiple sclerosis. Hum Genet. 2004, 114: 573-580. 10.1007/s00439-004-1095-9.
Article
CAS
PubMed
Google Scholar
Ristić S, Lovrecić L, Brajenović-Milić B, Starcević-Cizmarević N, Jazbec SS, Sepcić J, Kapović M: Mutations in the hemochromatosis gene (HFE) and multiple sclerosis. Neurosci Lett. 2005, 383: 301-304. 10.1016/j.neulet.2005.04.045.
Article
PubMed
Google Scholar
Ramagopalan SV, Cukjati M, Cernilec M, DeLuca GC, Dyment DA, Degenhardt A: Mutations in the hemochromatosis gene and the clinical outcome of multiple sclerosis. J Neuroimmunol. 2008, 203: 104-107. 10.1016/j.jneuroim.2008.06.036.
Article
CAS
PubMed
Google Scholar
Bettencourt A, Silva AM, Santos E, Gomes S, Mendonça D, Costa PP: HFE gene polymorphisms and severity in Portuguese patients with multiple sclerosis. Eur J Neurol. 2011, 18: 663-666. 10.1111/j.1468-1331.2010.03109.x.
Article
CAS
PubMed
Google Scholar
Abboud S, Haile DJ: A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J Biol Chem. 2000, 275: 19906-19912. 10.1074/jbc.M000713200.
Article
CAS
PubMed
Google Scholar
Altès A, Bach V, Ruiz A, Esteve A, Remacha AF, Sardà MP: Does the SLC40A1 gene modify HFE-related haemochromatosis phenotypes?. Ann Hematol. 2009, 88: 341-345. 10.1007/s00277-008-0590-9.
Article
PubMed
Google Scholar
Leong WI, Lönnerdal B: Hepcidin, the recently identified peptide that appears to regulate iron absorption. J Nutr. 2004, 134: 1-4.
CAS
PubMed
Google Scholar
Andreani M, Radio FC, Testi M, De Bernardo C, Troiano M, Majore S: Association of hepcidin promoter c.-582 A>G variant and iron overload in thalassemia major. Haematologica. 2009, 94: 1293-1296. 10.3324/haematol.2009.006270.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bruno F, Bonalumi S, Camaschella C, Ferrari M, Cremonesi L: The -582A>G variant of the HAMP promoter is not associated with high serum ferritin levels in normal subjects. Haematologica. 2010, 95: 849-850. 10.3324/haematol.2009.018986.
Article
CAS
PubMed
Google Scholar
Parajes S, González-Quintela A, Campos J, Quinteiro C, Domínguez F, Loidi L: Genetic study of the hepcidin gene (HAMP) promoter and functional analysis of the c.-582A > G variant. BMC Genet. 2010, 11: 110-
Article
CAS
PubMed
PubMed Central
Google Scholar
Aisen P: Transferrin, the transferrin receptor, and the uptake of iron by cells. Met Ions Biol Syst. 1998, 35: 585-631.
CAS
PubMed
Google Scholar
Lee PL, Ho NJ, O , Beutler E: The effect of transferrin polymorphisms on iron metabolism. Blood Cells Mol Dis. 1999, 25: 374-379. 10.1006/bcmd.1999.0267.
Article
CAS
PubMed
Google Scholar
Wong CT, Saha N: Effects of transferrin genetic phenotypes on total iron-binding capacity. Acta Haematol. 1986, 75: 215-218. 10.1159/000206128.
Article
CAS
PubMed
Google Scholar
Zambenedetti P, De Bellis G, Biunno I, Musicco M, Zatta P: Transferrin C2 variant does confer a risk for Alzheimer's disease in caucasians. J Alzheimers Dis. 2003, 5: 423-427.
CAS
PubMed
Google Scholar
Zhang P, Yang Z, Zhang C, Lu Z, Shi X, Zheng W: Association study between late-onset Alzheimer's disease and the transferrin gene polymorphisms in Chinese. Neurosci Lett. 2003, 349: 209-211. 10.1016/S0304-3940(03)00837-1.
Article
CAS
PubMed
Google Scholar
Kauwe JS: Alzheimer's Disease Neuroimaging Initiative: Suggestive synergy between genetic variants in TF and HFE as risk factors for Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet. 2010, 153B: 955-959.
Article
CAS
PubMed
PubMed Central
Google Scholar
Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L: Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol. 2005, 58: 840-846. 10.1002/ana.20703.
Article
PubMed
Google Scholar
Lublin FD: Clinical features and diagnosis of multiple sclerosis. Neurol Clin. 2005, 23: 1-15. 10.1016/j.ncl.2004.09.003.
Article
PubMed
Google Scholar
Roxburgh RH, Seaman SR, Masterman T, Hensiek AE, Sawcer SJ, Vukusic S, Achiti I, Confavreux C, Coustans M, le Page E, Edan G, McDonnell GV, Hawkins S, Trojano M, Liguori M, Cocco E, Marrosu MG, Tesser F, Leone MA, Weber A, Zipp F, Miterski B, Epplen JT, Oturai A, Sørensen PS, Celius EG, Lara NT, Montalban X, Villoslada P, Silva AM, Marta M, Leite I, Dubois B, Rubio J, Butzkueven H, Kilpatrick T, Mycko MP, Selmaj KW, Rio ME, Sá M, Salemi G, Savettieri G, Hillert J, Compston DA: Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity. Neurology. 2005, 64: 1144-1151. 10.1212/01.WNL.0000156155.19270.F8.
Article
CAS
PubMed
Google Scholar
Kotze MJ, de Villiers JN, Warnich L, Schmidt S, Carr J, Mansvelt E: Lack of clinical manifestation of hereditary haemochromatosis in South African patients with multiple sclerosis. Metab Brain Dis. 2006, 21: 109-120.
Article
CAS
PubMed
Google Scholar
Ristori G, Brescianini S, Pino A, Visconti A, Vittori D, Coarelli G: Serum elements and oxidative status in clinically isolated syndromes: imbalance and predictivity. Neurology. 2011, 76: 549-555. 10.1212/WNL.0b013e31820af7de.
Article
CAS
PubMed
Google Scholar
Zivadinov R, Schirda C, Dwyer MG, Haacke ME, Weinstock-Guttman B, Menegatti E, Heininen-Brown M, Magnano C, Malagoni AM, Wack DS, Hojnacki D, Kennedy C, Carl E, Bergsland N, Hussein S, Poloni G, Bartolomei I, Salvi F, Zamboni P: Chronic cerebrospinal venous insufficiency and iron deposition on susceptibility-weighted imaging in patients with multiple sclerosis: a pilot case–control study. Int Angiol. 2010, 29: 158-175.
CAS
PubMed
Google Scholar
Neema M, Arora A, Healy BC, Guss ZD, Brass SD, Duan Y: Deep gray matter involvement on brain MRI scans is associated with clinical progression in multiple sclerosis. J Neuroimaging. 2009, 19: 3-8. 10.1111/j.1552-6569.2008.00296.x.
Article
PubMed
PubMed Central
Google Scholar
Brass SD, Benedict RH, Weinstock-Guttman B, Munschauer F, Bakshi R: Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis. Mult Scler. 2006, 12: 437-444. 10.1191/135248506ms1301oa.
Article
CAS
PubMed
Google Scholar
Tjoa CW, Benedict RH, Weinstock-Guttman B, Fabiano AJ, Bakshi R: MRI T2 hypointensity of the dentate nucleus is related to ambulatory impairment in multiple sclerosis. J Neurol Sci. 2005, 234: 17-24. 10.1016/j.jns.2005.02.009.
Article
CAS
PubMed
Google Scholar
Rouault TA, Zhang DL, Jeong SY: Brain iron homeostasis, the choroid plexus, and localization of iron transport proteins. Metab Brain Dis. 2009, 24: 673-684. 10.1007/s11011-009-9169-y.
Article
CAS
PubMed
PubMed Central
Google Scholar
Pantopoulos K: Iron metabolism and the IRE/IRP regulator system: an update. Ann NY Acad Sci. 2004, 1012: 1-13. 10.1196/annals.1306.001.
Article
CAS
PubMed
Google Scholar
Ke Y, Qian ZM: Iron misregulation in the brain: a primary cause of neurodegenerative disorders. Lancet Neurol. 2003, 2: 246-253. 10.1016/S1474-4422(03)00353-3.
Article
CAS
PubMed
Google Scholar
Zamboni P, Menegatti E, Weinstock-Guttman B, Dwyer MG, Schirda CV, Malagoni AM, Hojnacki D, Kennedy C, Carl E, Bergsland N, Magnano C, Bartolomei I, Salvi F, Zivadinov R: Hypoperfusion of brain parenchyma is associated with the severity of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis: a cross-sectional preliminary report. BMC Med. 2011, 9: 22-10.1186/1741-7015-9-22.
Article
PubMed
PubMed Central
Google Scholar
Zamboni P, Galeotti R, Menegatti E, Malagoni AM, Tacconi G: Dall'Ara S, Bartolomei I, Salvi F: Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry. 2009, 80: 392-399.
Article
CAS
PubMed
Google Scholar
Ferlini A, Bovolenta M, Neri M, Gualandi F, Balboni A, Yuryev A, Salvi F, Gemmati D, Liboni A, Zamboni P: Custom CGH array profiling of copy number variations (CNVs) on chromosome 6p21.32 (HLA locus) in patients with venous malformations associated with multiple sclerosis. BMC Med Genet. 2010, 11: 64-
Article
PubMed
PubMed Central
Google Scholar
van Rensburg SJ, van Toorn R: The controversy of CCSVI and iron in multiple sclerosis: is ferritin the key?. Neurology. 2010, 75: 1581-1582. 10.1212/WNL.0b013e3181fb44f0.
Article
PubMed
Google Scholar
Ghezzi A, Comi G, Federico A: Chronic cerebro-spinal venous insufficiency (CCSVI) and multiple sclerosis. Neurol Sci. 2011, 32: 17-21. 10.1007/s10072-010-0458-3.
Article
CAS
PubMed
Google Scholar
D'haeseleer M, Cambron M, Vanopdenbosch L, De Keyser J: Vascular aspects of multiple sclerosis. Lancet Neurol. 2011, 10: 657-666. 10.1016/S1474-4422(11)70105-3.
Article
PubMed
Google Scholar
Williams R, Buchheit CL, Berman NE, Levine SM: Pathogenic implications of iron accumulation in multiple sclerosis. J Neurochem. 2012, 120: 7-25. 10.1111/j.1471-4159.2011.07536.x.
Article
CAS
PubMed
Google Scholar
Jacolot S, Yang Y, Paitry P, Férec C, Mura C: Iron metabolism in macrophages from HFE hemochromatosis patients. Mol Genet Metab. 2010, 101: 258-267. 10.1016/j.ymgme.2010.07.010.
Article
CAS
PubMed
Google Scholar
Mayr R, Janecke AR, Schranz M, Griffiths WJ, Vogel W, Pietrangelo A: Ferroportin disease: a systematic meta-analysis of clinical and molecular findings. J Hepatol. 2010, 53: 941-949. 10.1016/j.jhep.2010.05.016.
Article
CAS
PubMed
PubMed Central
Google Scholar
Masterman T, Ligers A, Olsson T, Andersson M, Olerup O, Hillert J: HLA-DR15 is associated with lower age at onset in multiple sclerosis. Ann Neurol. 2000, 48: 211-219. 10.1002/1531-8249(200008)48:2<211::AID-ANA11>3.0.CO;2-R.
Article
CAS
PubMed
Google Scholar
Todorich B, Pasquini JM, Garcia CI, Paez PM, Connor JR: Oligodendrocytes and myelination: the role of iron. Glia. 2009, 57: 467-478. 10.1002/glia.20784.
Article
PubMed
Google Scholar
Barnett MH, Prineas JW: Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol. 2004, 55: 458-468. 10.1002/ana.20016.
Article
PubMed
Google Scholar
Bartzokis G, Lu PH, Tishler TA, Peters DG, Kosenko A, Barrall KA, Finn JP, Villablanca P, Laub G, Altshuler LL, Geschwind DH, Mintz J, Neely E, Connor JR: Prevalent iron metabolism gene variants associated with increased brain ferritin iron in healthy older men. J Alzheimers Dis. 2010, 20: 333-341.
CAS
PubMed
PubMed Central
Google Scholar
Bartzokis G, Lu PH, Tingus K, Peters DG, Amar CP, Tishler TA, Finn JP, Villablanca P, Altshuler LL, Mintz J, Neely E, Connor JR: Gender and iron genes may modify associations between brain iron and memory in healthy aging. Neuropsychopharmacology. 2011, 36: 1375-1384. 10.1038/npp.2011.22.
Article
CAS
PubMed
PubMed Central
Google Scholar
van Rensburg SJ, Kotze MJ, van Toorn R: The conundrum of iron in multiple sclerosis - time for an individualised approach. Metab Brain Dis. 2012, 27: 239-253. 10.1007/s11011-012-9290-1.
Article
CAS
PubMed
PubMed Central
Google Scholar